Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
BMC Cancer|October 15, 2020
Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survivalTakaya Yamamoto, Yuzuru Niibe, Masahiko Aoki, et al.
Journal of Radiation Research|March 28, 2025
Contouring atlas and essential points for radiotherapy in rectal cancerKeiko Nemoto Murofushi, Kayoko Tsujino, Yoshinori Ito, et al.
Annals of Nuclear Medicine|April 12, 2007
Initial evaluation of dynamic human imaging using 18F-FRP170 as a new PET tracer for imaging hypoxiaTomohiro Kaneta, Yoshihiro Takai, Ren Iwata, et al.
BMC Cancer|April 9, 2010
Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCPKeiichi Jingu, Hisanori Ariga, Tomohiro Kaneta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2021
Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective studyYoko Tsukita, Takaya Yamamoto, Hiroshi Mayahara, et al.
Journal of Radiation Research|June 3, 2025
Radiotherapy treatment planning for esophageal cancer: JASTRO guidelines 2024 for radiotherapy treatment planningKeiichi Jingu, Keiji Nihei, Yoshinori Ito, et al.
Brachytherapy|December 26, 2017
Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution studyRei Umezawa, Naoya Murakami, Satoshi Nakamura, et al.
Clinical and Translational Radiation Oncology|September 6, 2022
The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non-small cell lung cancer: A multicenter retrospective cohort studyYuichiro Takeda, Yusaku Kusaba, Yoko Tsukita, et al.
Cancer Science|March 5, 2022
PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like featuresKatsuya Fukui, Miyuki Nomura, Kazuhiro Kishimoto, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|January 9, 2023
Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancerKazuya Takeda, Yoshihide Kawasaki, Toru Sakayauchi, et al.
Pageof 27